Publication | Open Access
Endocrine Therapy plus Zoledronic Acid in Premenopausal Breast Cancer
1K
Citations
41
References
2009
Year
The addition of zoledronic acid to adjuvant endocrine therapy improves disease-free survival in premenopausal patients with estrogen-responsive early breast cancer. (ClinicalTrials.gov number, NCT00295646.)
| Year | Citations | |
|---|---|---|
Page 1
Page 1